Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance

Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance

Cyclin‐dependent kinase 1 (CDK1) plays a significant role in certain malignancies. However, it remains unclear whether CDK1 plays a role in esophageal squamous cell carcinoma (ESCC). The aim of this study was to analyze the expression and clinical value of CDK1 in ESCC. CDK1 protein in 151 ESCC tiss...

Full description

Saved in:

Bibliographic Details
Main Authors:	Han‐Jie Zhang, Gang Chen, Shang‐Wei Chen, Zong‐Wang Fu, Hua‐Fu Zhou, Zhen‐Bo Feng, Jun‐Xian Mo, Chang‐Bo Li, Jun Liu
Format:	Article
Language:	English
Published:	Wiley 2021-11-01
Series:	FEBS Open Bio
Subjects:	cyclin dependent kinase 1 esophageal squamous cell carcinoma immunohistochemistry RNA‐seq
Online Access:	https://doi.org/10.1002/2211-5463.13306
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Research progress on cell cycle regulation-related molecules in the development of oral squamous cell carcinoma
by: HOU Zeyu, et al.
Published: (2023-04-01)

Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
by: Razia Rahman, et al.
Published: (2025-05-01)

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico
by: Kaori Asamitsu, et al.
Published: (2025-06-01)

Expression of Cyclin D1 in Oral Squamous Cell Carcinoma
by: Malak Abdulrahman Seid Ahmed, et al.
Published: (2021-12-01)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

Selective cyclin-dependent kinase 4/6 inhibitors as anticancer drugs: Moving beyond hormone receptor-positive breast cancer
by: Tamojit Chaudhuri, et al.
Published: (2019-01-01)

Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
by: Shun-Hua Chen, et al.
Published: (2025-06-01)

Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy
by: Jonatan Kaszubski, et al.
Published: (2024-11-01)

Cyclin dependent kinase 9 inhibitor induces transcription-replication conflicts and DNA damage accumulation in breast cancer
by: Minyoung Lee, et al.
Published: (2025-07-01)

Exploring the Therapeutic Potential of Antiaris africana: Targeting Cyclin-Dependent Kinases 8 and 13 for Cancer Treatment through Molecular Docking Studies
by: Mutiu A. Alabi, et al.
Published: (2025-06-01)

Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Radiotherapy in Curative Breast Cancer Patients Induced Pneumonitis: A Case Report
by: Pei-Yu Hou
Published: (2025-04-01)

Prognostic Value of Cyclin D1 Overexpression in Invasive Breast Carcinoma
by: Funda Taşlı, et al.
Published: (2025-04-01)

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 − advanced breast cancer: a meta-analysis
by: Isah Adamu Danbala, et al.
Published: (2025-06-01)

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review
by: N. A. Avxentyev, et al.
Published: (2024-05-01)

Complexity in cancer biology: is systems biology the answer?
by: Evangelia Koutsogiannouli, et al.
Published: (2013-04-01)

A CDKN2B-Associated Immune Prognostic Model for Predicting Immune Cell Infiltration and Prognosis in Esophageal Carcinoma
by: Peng X, et al.
Published: (2025-04-01)

THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS
by: S. L. Pavlinsky, et al.
Published: (2017-09-01)

LIMK1 as a Novel Kinase of β‐Catenin Promotes Esophageal Cancer Metastasis by Cooperating With CDK5
by: Shu‐Jun Li, et al.
Published: (2025-08-01)

Evaluation of Cyclin D1 protein and its association with the clinicopathological characteristics and prognosis of lung cancer: A retrospective study from Southern Kerala, India
by: Neeraja Panakkal, et al.
Published: (2024-12-01)

Immunohistochemical evaluation of P53 in squamous cell carcinoma of the esophagus
by: Kala K, et al.
Published: (2024-10-01)

Cyclin D1 expression in multiple myeloma by immunohistochemistry: Case series of 14 patients and literature review
by: Somanath Padhi, et al.
Published: (2013-01-01)

Histopathological characteristics and coexpression of p53 and p16INK4a proteins in renal cancer
by: Živković Slađana, et al.
Published: (2008-01-01)

Prognostic value of FDG PET/CT in de novo stage IV breast cancer patients treated with cyclin-dependent kinase 4/6 inhibitors
by: Wonseok Whi, et al.
Published: (2025-07-01)

Significance and limitations of routine p16/Ki-67 immunohistochemistry as a diagnostic tool for high-grade squamous intraepithelial lesions of the uterine cervix
by: Kazutaka Ozono, et al.
Published: (2025-01-01)

PTBP1 promotes IRES-mediated translation of cyclin B1<?A3B2 ACK?>in cancer
by: Fan Xinyi, et al.
Published: (2022-05-01)

Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma in vitro and in vivo
by: Yingying Yang, et al.
Published: (2024-12-01)

Nomograms for predicting the prognosis in multiple primary esophageal squamous cell carcinoma
by: Kexi Wang, et al.
Published: (2024-12-01)

Single-cell RNA sequencing of shoot apex reveals the mechanism of cyclin regulating cell division via auxin signaling pathway in Populus alba
by: Jing-hui Liang, et al.
Published: (2025-03-01)

PP1γ promotes esophageal squamous cell carcinoma progression through the PP1γ/YAP1/SOX2 axis
by: Juan Du, et al.
Published: (2025-06-01)

Metal-dependent cell death resistance contribute to lymph node metastasis of oral squamous cell carcinoma
by: Xuan-Hao Liu, et al.
Published: (2025-02-01)

The expression and clinical significance of PTK7 in oral squamous cell carcinoma
by: JIA Guodong, et al.
Published: (2023-04-01)

Consequence of the tumor‐associated conversion to cyclin D1b
by: Michael A Augello, et al.
Published: (2015-03-01)

Endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in patients with cirrhosis and esophageal varices
by: Tomoaki Mochimaru, et al.
Published: (2023-04-01)

Study of cytostatic and cytotoxic characteristics of modified peptide CDK4/6 inhibitors – functional analogs of p16INK4a (90-97)
by: V. K. Bozhenko, et al.
Published: (2021-01-01)

Complete Remission of Cutaneous Metastasis from Invasive Breast Cancer with Abemaciclib plus Letrozole
by: Shaunak N. Valame, et al.
Published: (2024-02-01)

Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1
by: Xiuzhi Zhang, et al.
Published: (2025-04-01)

Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
by: Shu Huang, et al.
Published: (2025-02-01)

Circulating Tumor DNA Dynamic Changes in Esophageal Squamous Cell Carcinoma Receiving Immunochemotherapy
by: Yijia Guo, et al.
Published: (2025-05-01)

Alkannin Induces G2/M-Phase Arrest, Apoptosis, and Inhibition of Invasion by Targeting GSK3β in Esophageal Squamous Cell Carcinoma
by: Ma H, et al.
Published: (2024-11-01)

Incidence trends of esophageal squamous cell and adenocarcinoma in Finland in 2000–2021
by: Pietari Junkala, et al.
Published: (2025-08-01)